Alcohol abuse and carbohydrate-deficient transferrin analysis: Are screening and confirmatory analysis required? [2]

Clinical Chemistry

Volumn 48, Issue 11, 2002, Pages 2072-2074

  Arndt, Torsten ^a   Kropf, Jürgen ^a  

^a Bioscientia Center for Human Genetics   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CANNABIS; CARBOHYDRATE DEFICIENT TRANSFERRIN; COCAINE; DIAMORPHINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE;

ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOLISM; ANALYTIC METHOD; CAPILLARY ELECTROPHORESIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DISEASE MARKER; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LABORATORY DIAGNOSIS; LABORATORY TEST; LETTER; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEAN CORPUSCULAR VOLUME; MEDICOLEGAL ASPECT; PROFESSIONAL PRACTICE; PROTEIN DETERMINATION; QUALITY CONTROL; SCREENING; VALIDATION PROCESS;

CANNABIS;

EID: 0036839834     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/48.11.2072     Document Type: Letter

References (16)

1. Stibler H. Carbohydrate-deficient transferrin in serum: A new marker of potentially harmful alcohol consumption reviewed, Clin Chem 1991;37:2029-37.
2. Arndt T. Carbohydrate-deficient transferrin as a marker of chronic alcohol abuse: A critical review of preanalysis, analysis, and interpretation. Clin Chem 2001;47:13-27.
3. Ferrara DS, Tedeschi L, Frison G, Brusini G. Quality control in toxicological analysis [Review]. J Chromatogr B Biomed Sci Appl 1998;713:227-43.
4. Schutz H. Screening von Drogen und Arzneimitteln mit Immunoassays. Wiesbaden: Wissen-schaftliche Verlagsabteilung Abbott GmbH, 1999.
5. Gough TA, ed. The Analysis of Drugs of Abuse. Chichester: John Wiley & Sons Ltd, 1991:628pp.
6. Observatoire Français des Drogues et de Toxicomanie. Drugs and Drug Addictions. Indicators and Trends, 1999 Édition:257pp, http://www. drogues.gouv.fr (Accessed September 1999).
7. Fahrenkrug H, Gmel G. Addictiveness: How Swiss experts rate alcohol and other drugs. Alcologia 1996;8:225-9.
8. Gibitz HJ, Schütz H, eds, Bestimmung von Ethanol in Serum, Durchführung und Interpretation im klinisch-chem schen Laboratorium. Mitteilung XX der Senatskommission für klinischtoxikologische Analytik. Weinheim: VCH Verlagsgesellschaft mbH, 1993:195pp.
9. Scouller K, Conigrave KM, Macaskill P, Irwig L, Whitfield JB. Should we use carbohydrate-deficient transferrin instead of γ-glutamyltransferase for detecting problem drinkers? A systematic review and meta-analysis. Clin Chem 2000;46:1894-902.
10. 2-transferrin in carbohydrate-deficient transferrin (CDT): A study on male alcoholics and hazardous drinkers. Med Sci Monit 2002;8:411-8.
11. Arndt T, Hackler R, Kleine TO, Gressner AM. Validation by isoelectric focusing of the anion-exchange isotransferrin fractionation step involved in determination of carbohydrate-deficient transferrin by the CDTect assay. Clin Chem 1998:44:27-34.
12. Hickey K, Seliem R, Shields J, McKee A, Nichols JH, A positive drug test in the pain management patient: Deception or herbal cross-reactivity? Clin Chem 2002;48:958-60.
13. Helander A, Eriksson G, Stibler H, Jeppsson J-O. Interference of transferrin isoform types with carbohydrate-deficient transferrin quantification in the identification of alcohol abuse. Clin Chem 2001;47:1222-33.
14. Peter J, Unverzagt C, Engel W-D, Renauer D, Seidel C, Hösel W, Identification of carbohydrate-deficient transferrin forms by MALDI-TOF mass spectrometry and lectin ELISA. Biochem Biophys Acta 1998;1380:93-101.
15. Giordano BC, Muza M, Trout A, Landers JP. Dynamically-coated capillaries allow for capillary electrophoretic resolution of transferrin sialoforms via direct analysis of human serum. J Chromatogr B Biomed Appl 2000;742:79-89.
16. Turpeinen U, Methuen T, Alfthan H, Laitinen K, Salaspuro M, Stenman UH. Comparison of HPLC and small column (CDTect) methods for disialotransferrin. Clin Chem 2001;47:1782-7.